Tenecteplase Fails to Boost EVT Outcomes - Quiz - MDSpire

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

Original Source(s)

Tenecteplase Fails to Boost EVT Outcomes

  • by Kathryn Wighton

  • May 14, 2026

Related Content

Psychological distress and caregiver burden among informal caregivers of patients with earthquake-related and stroke-related dependency: a comparative study

A systematic review on using intervention mapping to guide behavioral interventions for improving stroke patient outcomes

Cholinergic regulation of neuroinflammation: linking microglia, immunometabolism, and neuromodulation